• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

藻酸钠(吉福森)治疗早产儿胃食管反流的疗效。

The efficacy of sodium alginate (Gaviscon) for the treatment of gastro-oesophageal reflux in preterm infants.

机构信息

S. Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy.

出版信息

Aliment Pharmacol Ther. 2011 Feb;33(4):466-70. doi: 10.1111/j.1365-2036.2010.04545.x. Epub 2010 Dec 15.

DOI:10.1111/j.1365-2036.2010.04545.x
PMID:21158879
Abstract

BACKGROUND

Gastro-oesophageal reflux is common in preterm newborns; at present, no studies have evaluated the efficacy of sodium alginate in this population.

AIM

To evaluate the effect of sodium alginate on gastro-oesophageal reflux features in preterm newborns by combined pH and impedance monitoring (pH-MII).

METHODS

Thirty-two symptomatic preterm newborns underwent a 24 h pH-MII, during which each baby was fed eight times. Sodium alginate was given four times at alternate meals [drug-given (DG) vs. drug-free (DF) meals]. Gastro-oesophageal reflux features (i.e. number, acidity, duration and height of gastro-oesophageal reflux) after DG and DF meals were compared by Wilcoxon signed ranks test.

RESULTS

Sodium alginate significantly decreased the number of acid gastro-oesophageal reflux detected either by pH monitoring (DG vs. DF: median 17.00 vs. 29.00, P = 0.002) and MII (DG vs. DF: 4.0 vs. 6.00, P = 0.050), and also acid oesophageal exposure (DG vs. DF: 4.0% vs. 7.6%, P = 0.030), without any influence on non-acid gastro-oesophageal reflux. Furthermore, it decreased the number of gastro-oesophageal reflux reaching proximal oesophagus (DG vs. DF: 5.50 vs. 7.50, P = 0.030).

CONCLUSIONS

The use of sodium alginate in preterm infants seems to be promising, because this drug decreases gastro-oesophageal reflux acidity and height with the advantage of a nonsystemic way of action and a more favourable safety profile over H2 blockers and PPIs.

摘要

背景

胃食管反流在早产儿中很常见;目前,尚无研究评估海藻酸钠在该人群中的疗效。

目的

通过联合 pH 和阻抗监测(pH-MII)评估海藻酸钠对早产儿胃食管反流特征的影响。

方法

32 例有症状的早产儿进行了 24 小时 pH-MII 检查,在此期间,每个婴儿喂食 8 次。海藻酸钠在 4 次喂食时(用药组 [DG] 与无药组 [DF])交替给予。通过 Wilcoxon 符号秩检验比较 DG 和 DF 餐后胃食管反流特征(即胃食管反流次数、酸度、持续时间和高度)。

结果

海藻酸钠显著减少了 pH 监测(DG 与 DF:中位数 17.00 比 29.00,P = 0.002)和 MII (DG 与 DF:4.0 比 6.00,P = 0.050)检测到的酸胃食管反流次数,也减少了酸食管暴露(DG 与 DF:4.0%比 7.6%,P = 0.030),但对非酸胃食管反流没有影响。此外,它还减少了到达食管近端的胃食管反流次数(DG 与 DF:5.50 比 7.50,P = 0.030)。

结论

海藻酸钠在早产儿中的应用似乎很有前景,因为这种药物可以降低胃食管反流的酸度和高度,且具有非系统性作用方式和比 H2 阻滞剂和质子泵抑制剂更有利的安全性特征。

相似文献

1
The efficacy of sodium alginate (Gaviscon) for the treatment of gastro-oesophageal reflux in preterm infants.藻酸钠(吉福森)治疗早产儿胃食管反流的疗效。
Aliment Pharmacol Ther. 2011 Feb;33(4):466-70. doi: 10.1111/j.1365-2036.2010.04545.x. Epub 2010 Dec 15.
2
Gaviscon for gastro-oesophageal reflux in infants: a poorly effective treatment?加胃斯康用于治疗婴儿胃食管反流:一种疗效不佳的治疗方法?
Arch Dis Child. 2006 Jan;91(1):93. doi: 10.1136/adc.2005.086355.
3
[Estimation of efficiency of alginate-raft barrier in treatment of gastroesophageal reflux disease].[藻酸盐漂浮屏障治疗胃食管反流病的疗效评估]
Eksp Klin Gastroenterol. 2008(6):77-81.
4
Effect of Gaviscon Infant on gastro-oesophageal reflux in infants assessed by combined intraluminal impedance/pH.通过联合腔内阻抗/pH评估加胃喜婴儿制剂对婴儿胃食管反流的影响。
Arch Dis Child. 2005 May;90(5):460-3. doi: 10.1136/adc.2002.024463.
5
Sodium Alginate (Gaviscon®) does not reduce apnoeas related to gastro-oesophageal reflux in preterm infants.藻酸钠(吉福森)不能减少与早产儿胃食管反流相关的呼吸暂停。
Early Hum Dev. 2011 Dec;87(12):775-8. doi: 10.1016/j.earlhumdev.2011.05.013. Epub 2011 Jun 22.
6
[Alginate-containing preparation gaviscon for patients with gastroesophaginal reflux complicated with chronic pancreatitis: pathogenetic substantiation of clinical use prospects].含藻酸盐制剂盖胃平用于胃食管反流合并慢性胰腺炎患者:临床应用前景的发病机制依据
Eksp Klin Gastroenterol. 2008(1):96-101.
7
[Treatment with sodium alginate of gastroesophageal reflux disease in childhood: efficacy and tolerance assessment].[海藻酸钠治疗儿童胃食管反流病:疗效与耐受性评估]
Pediatr Med Chir. 2001 May-Aug;23(3-4):187-9.
8
A comparison between cisapride and Gaviscon with Carobel in the treatment of gastro-oesophageal reflux in infancy.西沙必利与加味氢氧化铝和角豆树胶治疗婴儿胃食管反流的比较。
Ir Med J. 1992;85(4 Suppl):14.
9
[Alginate-raft preparations in the treatment of acid reflux and heartburn (literature review)].藻酸盐漂浮制剂治疗胃酸反流和烧心(文献综述)
Eksp Klin Gastroenterol. 2008(4):64-77.
10
Comparative study of Algicon versus Gaviscon in symptomatic gastro-oesophageal reflux.症状性胃食管反流中Algicon与Gaviscon的对比研究
Br J Clin Pract Suppl. 1989 Feb;66:52-5; discussion 61-4.

引用本文的文献

1
Evaluating the reflux suppression properties of Gaviscon Infant powder with different milk formulations using an in vitro model of the infant stomach.使用婴儿胃的体外模型评估不同牛奶配方的胃喜康婴儿粉剂的反流抑制特性。
Sci Rep. 2025 Feb 8;15(1):4787. doi: 10.1038/s41598-025-88638-5.
2
Improving growth in preterm infants through nutrition: a practical overview.通过营养改善早产儿生长:实用概述
Front Nutr. 2024 Sep 10;11:1449022. doi: 10.3389/fnut.2024.1449022. eCollection 2024.
3
Prescriptions of anti-reflux drugs in neonatology and neonatal intensive care units: A large multicentre observational study (2014-2022).
新生儿科和新生儿重症监护病房中抗反流药物的处方:一项大型多中心观察性研究(2014-2022 年)。
Br J Clin Pharmacol. 2024 Dec;90(12):3201-3211. doi: 10.1111/bcp.16198. Epub 2024 Aug 7.
4
Pharmacological treatment of gastro-oesophageal reflux in children.儿童胃食管反流病的药物治疗。
Cochrane Database Syst Rev. 2023 Aug 22;8(8):CD008550. doi: 10.1002/14651858.CD008550.pub3.
5
Potential applications of algae in biochemical and bioenergy sector.藻类在生化和生物能源领域的潜在应用。
3 Biotech. 2021 Jun;11(6):296. doi: 10.1007/s13205-021-02825-5. Epub 2021 May 24.
6
Magnesium Alginate in Gastro-Esophageal Reflux: A Randomized Multicenter Cross-Over Study in Infants.藻酸镁在胃食管反流中的应用:一项针对婴儿的随机多中心交叉研究。
Int J Environ Res Public Health. 2019 Dec 20;17(1):83. doi: 10.3390/ijerph17010083.
7
Alginates: From the ocean to gastroesophageal reflux disease treatment.藻酸盐:从海洋到胃食管反流病治疗
Turk J Gastroenterol. 2019 Sep;30(Suppl2):109-136. doi: 10.5152/tjg.2019.19677.
8
Gastroesophageal reflux in children: an updated review.儿童胃食管反流:最新综述
Drugs Context. 2019 Jun 17;8:212591. doi: 10.7573/dic.212591. eCollection 2019.
9
Optimizing the Use of Medications and Other Therapies in Infant Gastroesophageal Reflux.优化婴儿胃食管反流病的药物和其他疗法的使用。
Paediatr Drugs. 2018 Dec;20(6):523-537. doi: 10.1007/s40272-018-0311-3.
10
The Effect of Alginate in Gastroesophageal Reflux in Infants.藻酸盐在婴儿胃食管反流中的作用。
Paediatr Drugs. 2018 Dec;20(6):575-583. doi: 10.1007/s40272-018-0314-0.